Efficacy of intravitreal bevacizumab to treat retinal angiomatous proliferation stage II and III

European Journal of Ophthalmology

Volumn 19, Issue 3, 2009, Pages 448-451

  Montero, Javier A ^a,b   Fernandez, Maria I ^c   Gomez Ulla, Francisco ^c   Ruiz Moreno, José M ^b,d  

^a HOSPITAL UNIVERSITARIO RÍO HORTEGA   (Spain)

^b VISSUM ^*  (Spain)

^c UNIVERSITY OF SANTIAGO DE COMPOSTELA   (Spain)

^d UNIVERSITY OF CASTILLA LA MANCHA   (Spain)

Author keywords

Bevacizumab; Choroidal neovascularization; Retinal angiomatous proliferation; Retinal pigment epithelium tear

Indexed keywords

BEVACIZUMAB; INDOCYANINE GREEN; ANGIOGENESIS INHIBITOR; COLORING AGENT; DIAGNOSTIC AGENT; MONOCLONAL ANTIBODY; VASCULOTROPIN A;

AGED; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DRUG EFFICACY; FEMALE; HUMAN; MALE; OPTICAL COHERENCE TOMOGRAPHY; OUTCOME ASSESSMENT; PRIORITY JOURNAL; RETINA ANGIOMATOUS PROLIFERATION; RETINA FLUORESCEIN ANGIOGRAPHY; RETINA MACULA AGE RELATED DEGENERATION; SUBRETINAL FLUID; VISUAL ACUITY; CLASSIFICATION; CLINICAL TRIAL; DRUG ANTAGONISM; FLUORESCENCE ANGIOGRAPHY; HEMANGIOMATOSIS; INJECTION; MULTICENTER STUDY; RETINA DISEASE; RETROSPECTIVE STUDY; TREATMENT OUTCOME; VITREOUS BODY;

AGED; ANGIOGENESIS INHIBITORS; ANGIOMATOSIS; ANTIBODIES, MONOCLONAL; COLORING AGENTS; FEMALE; FLUORESCEIN ANGIOGRAPHY; HUMANS; INDOCYANINE GREEN; INJECTIONS; MALE; RETINAL DISEASES; RETROSPECTIVE STUDIES; TOMOGRAPHY, OPTICAL COHERENCE; TREATMENT OUTCOME; VASCULAR ENDOTHELIAL GROWTH FACTOR A; VISUAL ACUITY; VITREOUS BODY;

EID: 66149134002     PISSN: 11206721     EISSN: None     Source Type: Journal    
DOI: 10.1177/112067210901900320     Document Type: Article

References (15)

1. Freund KB, Ho IV, Barbazetto IA, et al. Type 3 neovascularization: the expanded spectrum of retinal angiomatous proliferation. Retina 2008; 28: 201-11.
2. Wolf A, Kook D, Kreutzer T, et al. Anti-VEGF treatment for retinal angiomatous proliferation. Ophthalmologe 2008; 105: 845-51.
3. Saito M, Shiragami C, Shiraga F, Nagayama D, Iida T. combined intravitreal bevacizumab and photodynamic therapy for retinal angiomatous proliferation. Am J Ophthalmol 2008; 146: 935-41.
4. Ghazi NG, Knape RM, Kirk TQ, Tiedeman JS, Conway BP. Intravitreal bevacizumab (Avastin) treatment of retinal angiomatous proliferation. Retina 2008; 28: 689-95.
5. Meyerle CB, Freund KB, Iturralde D, et al. Intravitreal bevacizumab (Avastin) for retinal angiomatous proliferation. Retina 2007; 27: 451-7.
6. Joeres S, Heussen FM, Treziak T, Bopp S, Joussen AM. Bevacizumab (Avastin) treatment in patients with retinal angiomatous proliferation. Graefes Arch Clin Exp Ophthalmol 2007; 245: 1597-602.
7. Costagliola C, Romano MR, dell'Omo R, Cipollone U, Polisena P. Intravitreal bevacizumab for the treatment of retinal angiomatous proliferation. Am J Ophthalmol 2007; 144: 449-51.
8. Lai TY, Chan WM, Liu DT, Lam DS. Ranibizumab for retinal angiomatous proliferation in neovascular agerelated macular degeneration. Graefes Arch Clin Exp Ophthalmol 2007; 245: 1877-80.
9. Kloos P, Bernasconi P, Estermann S, et al. Visual acuity and magnification requirement after ranibizumab in patients with wet age-related macular degeneration. Klin Monatsbl Augenheilkd 2008; 225: 385-91.
10. Yannuzzi LA, Negrao S, Iida T, et al. Retinal angiomatous proliferation in age-related macular degeneration. Retina 2001; 21: 416-34.
11. Bottoni F, Massacesi A, Cigada M, et al. Treatment of retinal angiomatous proliferation in age-related macular degeneration: a series of 104 cases of retinal angiomatous proliferation. Arch Ophthalmol 2005; 123: 1644-50.
12. Slakter JS, Yannuzzi LA, Schneider U, et al. Retinal choroidal anastomoses and occult choroidal neovascularization in age-related macular degeneration. Ophthalmology 2000; 107: 742-54.
13. Abi-Ayad N, Mauget-Faysse M, Amara-Allieu S, Ardisson P. Systemic bevacizumab for retinal angiomatous proliferation associated with retinal pigment epithelial detachment. Eur J Ophthalmol 2007; 17: 987-91.
14. Panagiotidis D, Karagiannis DA, Baltatzis S. Photodynamic therapy in retinal angiomatous proliferation stage I. Eur J Ophthalmol 2006; 16: 326-9.
15. Krebs I, Krepler K, Stolba U, Goll A, Binder S. Retinal angiomatous proliferation: combined therapy of intravitreal triamcinolone acetonide and PDT versus PDT alone. Graefes Arch Clin Exp Ophthalmol 2008; 246: 237-43.